Aging, neurocognitive impairment and adherence to antiretroviral therapy in human immunodeficiency virus-infected individuals
- PMID:27789283
- PMCID: PMC9427649
- DOI: 10.1016/j.bjid.2016.09.006
Aging, neurocognitive impairment and adherence to antiretroviral therapy in human immunodeficiency virus-infected individuals
Abstract
Background/objective: There is an increasing number of older patients with human immunodeficiency virus infection due to the success of antiretroviral therapy, the improved prognosis and life expectancy of patients, and the higher number of new infections among older individuals. The main objective of the present study was to compare the characteristics of older human immunodeficiency virus patients with those of younger patients.
Materials and methods: We conducted a cross-sectional study with human immunodeficiency virus-infected patients who were treated at the Specialized Care Service (Serviço de Assistência Especializada) for human immunodeficiency virus/AIDS in the city of Pelotas, South Brazil. Sociodemographic information as well as data on human immunodeficiency virus infection and treatment were collected. All participants underwent psychiatric and neurocognitive assessments, and their adherence to antiretroviral therapy was evaluated.
Results: A total of 392 patients participated in the study, with 114 patients aged 50 years and older. The characteristics showing significant differences between older and younger human immunodeficiency virus-infected patients included race/ethnicity, comorbidities, duration and adherence to antiretroviral therapy, currently undetectable viral load, and cognitive impairment. Compared to younger patients, older patients were at higher risk of exhibiting cognitive impairment [OR 2.28 (95% CI: 1.35-3.82, p=0.002)] and of having increased adherence to antiretroviral therapy [OR 3.11 (95% CI: 1.67-5.79, p<0.001)].
Conclusions: The prevalence of neurocognitive impairment remained high in human immunodeficiency virus-infected patients despite antiretroviral therapy. In the present study, the prevalence of this type of impairment was significantly higher in patients aged ≥50 years, most likely due to aging, human immunodeficiency virus infection, and a possible synergistic effect between these factors. Despite this higher prevalence, older patients exhibited higher rates of adherence to antiretroviral therapy and of undetectable human immunodeficiency virus viral load.
Keywords: Adherence; Aging; HIV; Neurocognitive impairment.
Copyright © 2016 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda. All rights reserved.
Similar articles
- Impact of aging on neurocognitive performance in previously antiretroviral-naive HIV-infected individuals on their first suppressive regimen.Coban H, Robertson K, Smurzynski M, Krishnan S, Wu K, Bosch RJ, Collier AC, Ellis RJ.Coban H, et al.AIDS. 2017 Jul 17;31(11):1565-1571. doi: 10.1097/QAD.0000000000001523.AIDS. 2017.PMID:28471765Free PMC article.Clinical Trial.
- Concurrent use of comedications reduces adherence to antiretroviral therapy among HIV-infected patients.Cantudo-Cuenca MR, Jiménez-Galán R, Almeida-Gonzalez CV, Morillo-Verdugo R.Cantudo-Cuenca MR, et al.J Manag Care Spec Pharm. 2014 Aug;20(8):844-50. doi: 10.18553/jmcp.2014.20.8.844.J Manag Care Spec Pharm. 2014.PMID:25062078Free PMC article.
- Factors associated with therapeutic success in HIV-positive individuals in southern Brazil.Silveira MP, Maurer P, Guttier MC, Moreira LB.Silveira MP, et al.J Clin Pharm Ther. 2015 Apr;40(2):192-5. doi: 10.1111/jcpt.12233. Epub 2014 Nov 25.J Clin Pharm Ther. 2015.PMID:25422132Clinical Trial.
- Human immunodeficiency virus in an aging population, a complication of success.Kirk JB, Goetz MB.Kirk JB, et al.J Am Geriatr Soc. 2009 Nov;57(11):2129-38. doi: 10.1111/j.1532-5415.2009.02494.x. Epub 2009 Sep 28.J Am Geriatr Soc. 2009.PMID:19793157Review.
- Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.Van Vaerenbergh K.Van Vaerenbergh K.Verh K Acad Geneeskd Belg. 2001;63(5):447-73.Verh K Acad Geneeskd Belg. 2001.PMID:11813503Review.
Cited by
- Ongoing Healthcare Disparities in neuroHIV: Addressing Gaps in the Care Continuum.Jia DT, Carcamo PM, Diaz MM.Jia DT, et al.Curr HIV/AIDS Rep. 2023 Dec;20(6):368-378. doi: 10.1007/s11904-023-00683-9. Epub 2023 Nov 24.Curr HIV/AIDS Rep. 2023.PMID:37999827Review.
- A Review of Long-Term Toxicity of Antiretroviral Treatment Regimens and Implications for an Aging Population.Chawla A, Wang C, Patton C, Murray M, Punekar Y, de Ruiter A, Steinhart C.Chawla A, et al.Infect Dis Ther. 2018 Jun;7(2):183-195. doi: 10.1007/s40121-018-0201-6. Epub 2018 May 14.Infect Dis Ther. 2018.PMID:29761330Free PMC article.Review.
- Antiretroviral drug use and HIV drug resistance among MSM and transgender women in sub-Saharan Africa.Zhang Y, Fogel JM, Guo X, Clarke W, Breaud A, Cummings V, Hamilton EL, Ogendo A, Kayange N, Panchia R, Dominguez K, Chen YQ, Sandfort T, Eshleman SH.Zhang Y, et al.AIDS. 2018 Jun 19;32(10):1301-1306. doi: 10.1097/QAD.0000000000001839.AIDS. 2018.PMID:29794492Free PMC article.
- Characterization of HIV-Associated Neurocognitive Impairment in Middle-Aged and Older Persons With HIV in Lima, Peru.Diaz MM, Zacarías MG, Sotolongo P, Sanes MF, Franklin DJ, Marquine MJ, Cherner M, Cárcamo C, Ellis RJ, Lanata S, García PJ.Diaz MM, et al.Front Neurol. 2021 Jun 17;12:629257. doi: 10.3389/fneur.2021.629257. eCollection 2021.Front Neurol. 2021.PMID:34220665Free PMC article.
- Is There Any Evidence of Premature, Accentuated and Accelerated Aging Effects on Neurocognition in People Living with HIV? A Systematic Review.Aung HL, Aghvinian M, Gouse H, Robbins RN, Brew BJ, Mao L, Cysique LA.Aung HL, et al.AIDS Behav. 2021 Mar;25(3):917-960. doi: 10.1007/s10461-020-03053-3. Epub 2020 Oct 6.AIDS Behav. 2021.PMID:33025390Free PMC article.
References
- Palella F.J., Jr., Delaney K.M., Moorman A.C., et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New Engl J Med. 1998;338:853–860. - PubMed
- Masiá M., Padilla S., Álvarez D., et al. Risk, predictors, and mortality associated with non-AIDS events in newly diagnosed HIV-infected patients: role of antiretroviral therapy. AIDS. 2013;27:181–189. - PubMed
- Guaraldi G., Orlando G., Zona S., et al. Premature age related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis. 2011;53:1120–1126. - PubMed
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical